- Home
- PRME vs FFC Comparison
PRME vs FFC Comparison
Compare PRME & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRME | FFC |
|---|---|---|
| Founded | 2019 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 796.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRME | FFC |
|---|---|---|
| Price | $3.22 | $16.79 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.42 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 164.1K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,977,000.00 | N/A |
| Revenue This Year | $95.64 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 647.13 | N/A |
| 52 Week Low | $1.11 | $11.90 |
| 52 Week High | $6.94 | $14.96 |
Technical Indicators
Market Signals| Indicator | PRME | FFC |
|---|---|---|
| Relative Strength Index (RSI) | 36.71 | 62.38 |
| Support Level | $4.08 | $16.47 |
| Resistance Level | $4.21 | $16.85 |
| Average True Range (ATR) | 0.36 | 0.13 |
| MACD | -0.10 | 0.03 |
| Stochastic Oscillator | 2.63 | 92.71 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.